-
Phase 1 Study of BT-409, a potent, selective, brain-penetrant, and oral small molecule inhibitor of NLRP3 in Healthy Volunteers and Adults with Parkinson’s disease
-
Phase 2 Trial for the Treatment of Early-stage Parkinson’s Disease with TJ0113, a Small Molecule Mitophagy Activator
-
Phasic Hemidystonia Secondary to Cavernoma: A Case of Sustained Response to Botulinum Toxin
-
Phenoconversion from Rapid Eye Movement Sleep Behavior Disorder to Parkinson’s Disease: A multimodal Imaging Study
-
Phenomenological Gaps in Rating Scales for Blepharospasm Motor Severity
-
Phenotype – lesion correlation in post-stroke movement disorders: Lessons learnt from two cases
-
Phenotypic and Genotypic Spectrum of MAPT-associated Parkinsonism in a Multi-ethnic Malaysian Cohort
-
Phenotypic Evolution from Nonfluent PPA to PSP
-
Phenotypic Overlap Between Essential Tremor and Dystonic Tremor: Diagnostic Features, Misclassification, and Clinical Implications :A Systematic Review
-
Phenotypic Spectrum, Neuroimaging Findings, Genotypic Correlates, and Treatment Outcomes in KMT2B-Related Disorder: A Multicenter Retrospective Cohort Study
- « Previous Page
- 1
- …
- 145
- 146
- 147
- 148
- 149
- …
- 208
- Next Page »
